Employees: 12 (2023.0)Legal category: 5485Size: PMECreation date: 2011-07-18 (14 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: QUETIGNY (21800), Cote-d'Or
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE GRAND QUETIGNY : revenue, balance sheet and financial ratios
PHARMACIE GRAND QUETIGNY is a French company
founded 14 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in QUETIGNY (21800),
this company of category PME
shows in 2023 a net income positive of 138 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE GRAND QUETIGNY (SIREN 533622312)
Indicator
2023
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
Net income
138 456 €
280 973 €
305 791 €
267 807 €
255 370 €
EBITDA
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE GRAND QUETIGNY generates positive net income of 138 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 255 k€ -> 138 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
138 456 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 99%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 42%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
98.723%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
42.418%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE GRAND QUETIGNY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2023
Debt ratio
576.385
361.327
246.076
199.999
98.723
Financial autonomy
12.849
18.723
24.446
28.44
42.418
Repayment capacity
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
98.722023
2018
2019
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average-14 pts over 3 years
In 2023, the debt ratio of PHARMACIE GRAND QUETIGNY (98.72) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
42.42%2023
2018
2019
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average+13 pts over 3 years
In 2023, the financial autonomy of PHARMACIE GRAND QUETIGNY (42.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 141.95. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
141.95
Liquidity indicators evolution PHARMACIE GRAND QUETIGNY
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2023
Liquidity ratio
117.923
118.484
116.34
141.928
141.95
Interest coverage
None
None
None
None
None
Sector positioning
Liquidity ratio
141.952023
2018
2019
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Average
In 2023, the liquidity ratio of PHARMACIE GRAND QUETIGNY (141.95) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE GRAND QUETIGNY in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE GRAND QUETIGNY is estimated at
1 633 708 €
(range 993 536€ - 2 296 627€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
993k€1633k€2296k€
1 633 708 €Range: 993 536€ - 2 296 627€
NAF 5 année 2023
Valuation method used
Net Income Multiple
138 456 €
×
11.8x
=1 633 708 €
Range: 993 536€ - 2 296 627€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE GRAND QUETIGNY with other companies in the same sector:
Frequently asked questions about PHARMACIE GRAND QUETIGNY
What is the revenue of PHARMACIE GRAND QUETIGNY ?
The revenue of PHARMACIE GRAND QUETIGNY is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE GRAND QUETIGNY profitable?
Yes, PHARMACIE GRAND QUETIGNY generated a net profit of 138 k€ in 2023.
Where is the headquarters of PHARMACIE GRAND QUETIGNY ?
The headquarters of PHARMACIE GRAND QUETIGNY is located in QUETIGNY (21800), in the department Cote-d'Or.
Where to find the tax return of PHARMACIE GRAND QUETIGNY ?
The tax return of PHARMACIE GRAND QUETIGNY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE GRAND QUETIGNY operate?
PHARMACIE GRAND QUETIGNY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart